Idexx Laboratories, Inc. IX1

XET: IX1 | ISIN: US45168D1046   17/05/2024
497,30 EUR (0,00%)
(0,00%)   17/05/2024

15 februari 2024 · IDEXX Launches Vello™, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect · Persbericht

12 januari 2024 · IDEXX Expands Fecal Dx® Antigen Testing Platform with Cystoisospora Detection, Marking the Second Platform Expansion in Less than Two Years · Persbericht

12 januari 2024 · IDEXX Announces Revolutionary Slide-Free Cellular Analyzer, IDEXX inVue Dx™ Transforming In-Clinic Workflows · Persbericht

8 november 2023 · IDEXX Expands SNAP Platform with Leish 4Dx Test to Support Veterinarians Globally in Diagnosing Vector-borne Diseases · Persbericht

25 juli 2023 · IDEXX Releases 2022 Corporate Responsibility Report, Providing Environmental, Social, and Governance Updates · Persbericht

15 juni 2023 · IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing Portfolio · Persbericht

21 februari 2023 · IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences · Persbericht

20 februari 2023 · Groundbreaking IDEXX Study Reveals Opportunities to Increase Veterinary Practice Productivity · Persbericht

6 februari 2023 · IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results · Persbericht

26 januari 2023 · IDEXX Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results · Persbericht

22 december 2022 · IDEXX Laboratories to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference · Persbericht

1 november 2022 · IDEXX Laboratories Announces Third Quarter Results · Persbericht

11 oktober 2022 · IDEXX Laboratories to Release 2022 Third Quarter Financial Results · Persbericht

2 augustus 2022 · IDEXX Laboratories Announces Second Quarter Results · Persbericht

8 juli 2022 · IDEXX Laboratories to Release 2022 Second Quarter Financial Results · Persbericht

21 juni 2022 · IDEXX Empowers Veterinarians with New Testing Insights that Support Earlier Diagnosis and Intervention for Preventive Care and Critical Cases · Persbericht

18 mei 2022 · IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day · Persbericht

4 mei 2022 · IDEXX Laboratories Announces First Quarter Results · Persbericht

11 april 2022 · IDEXX Laboratories to Release 2022 First Quarter Financial Results · Persbericht

17 februari 2022 · IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences · Persbericht

Mijn selecties